Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karaman Nuretti̇nfiledCriticalKaraman Nuretti̇n
Priority to TR2007/01721UpriorityCriticalpatent/TR200701721U/tr
Publication of TR200701721UpublicationCriticalpatent/TR200701721U/tr
Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene.
Uso de trastuzumab para la prevencion o reduccion de la metastasis en un paciente que padece de cancer her2 positivo, que no responde a una monoterapia con trastuzumab ni a una monoterapia con pertuzumab.